ResMed Inc. FY 2025 10-K, explained in plain English

Key financials — as reported

Total revenue	$5.1B
Gross margin	59.4%
Operating income	$1.7B
Net income	$1.4B
Diluted EPS	$9.51
Cash & equivalents	$1.2B
Total assets	$8.2B
Long-term debt	$658.4M

Key takeaway

ResMed reported $5.15 billion in revenue and $1.40 billion in net income for fiscal year 2025, with a 59.4% gross margin.

🔒 4 more takeaways in the full analysis

Beneath the surface

Cash of $1.21 billion versus total debt of about $668 million suggests a net cash position of roughly $541 million, better than the headline long-term debt figure alone implies.

🔒 4 more insights a headline reader would miss